Researchers believe that they can prevent children from developing type 1 diabetes by regulating their intestinal flora with probiotics when they are babies.
Children with type 1 diabetes show no signs of autoimmune disease as newborns. They don’t show signs of illness until they are four to six years old, according to Stanford Children’s Health. However, there are newborn screenings that can be used to determine if a person will develop type 1 diabetes as they age. For these babies in particular, a new study is expected to show that giving babies oral probiotics can prevent the risk of developing type 1 diabetes.
According to researchers at the Helmholtz Zentrum München and the Technical University of Dresden, intestinal health can be the key to preventing children from developing type 1 diabetes. That’s because Previous studies have shown that “intestinal flora imbalances” exist when children are diagnosed with the autoimmune diseaseaccording to EurekAlert! A study will therefore be carried out in Europe from April 2021 to determine whether Adding probiotics to a baby’s daily diet can completely prevent future chances of developing type 1 diabetes.
Finding a way to eradicate type 1 diabetes before it starts is important because, according to BeyondType1, the number of people diagnosed with the autoimmune disease is increasing worldwide every year. Most of the countries whose diabetes information was collected, including the US, Canada, New Zealand, various areas of the UK, China, India, and other countries, have shown that young people have the highest increases in diagnoses than any other age group.
To be included in the SINT1A study (B. Infantis Supplement for Relief of Type 1 Diabetes) Autoimmunity babies must demonstrate that they are predisposed to develop type 1 diabetes by collecting a few drops of blood from a newborn according to News-Medical.net.
When included in SINT1A, a daily dose of probiotics containing a strain of Bifidobacterium Infantis is given. According to Bioengineer.org, the probiotic’s job is to balance the intestinal flora, stop an autoimmune reaction, and prevent insulin-producing cells from being destroyed.
The SINT1A study hopes that through healthy intestinal health, the body can “better distinguish antigens that are safe from those that are dangerous,” said Professor Bonifacio from the Technical University of Dresden via EurekAlert!
If so, SINT1A will be combined with another study, the current primary oral insulin study, in which the body is trained not to have an autoimmune response to insulin from the gut.
Since both treatments are provided to those with markers showing they develop type 1 diabetes as they age, type 1 diabetes should be able to be eradicated completely.
Source: EurekAlert !, BioEngineer.org, News-Medical.net, BeyondType1, Stanford Children’s Health
About the author
Jessica Tucker
(1074 articles published)
Jessica is a writer from California. She is the mother of two extremely independent, fun-loving girls and the wife of a man who helps her find a balance in life. Jessica is an avid runner, consumer of really great cups of coffee, and enjoys adventures off the beaten track whenever possible. Family is number one for Jessica and makes life worthwhile in this crazy, hectic and beautiful life.
More from Jessica Tucker
